Advertisement
Advertisement

SNPX

SNPX logo

Synaptogenix Inc

2.69
USD
+0.01
+0.37%
Dec 13, 15:40 UTC -5
Open

Synaptogenix Inc Profile

About

Synaptogenix Inc. is an emerging biopharmaceutical company. It focused on developing therapies for neurodegenerative diseases. The company's lead therapeutic candidate consist Bryostatin-1. Synaptogenix Inc. is based in NEW YORK.

Info & Links

CEO

Alan Tuchman

Headquarters

1185 Avenue of the Americas, 3rd Floor
New York, NY 10036, UNITED STATES

Auditor

Morison Cogen LLP

Share holders

195

Employees

5

Synaptogenix Inc Statistics

Valuation Measures

Market Capitalization2

3.66M

Enterprise Value

-15.97M

Enterprise Value/EBITDA(ttm)

2.36

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.28

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-42.14%

Return on Invested Capital(ttm)

-55.35%

Return on Assets(ttm)

-29.42%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-6.76M

Net Income Available to Common(ttm)

-9.13M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.18

52-Week Change

-57.82%

S&P 500 52-Week Change

26.39%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.36M

Dividend Yield

0.00%

Float4

1.32M

% Held by Insiders

2.73%

% Held by Institutions

10.34%

Balance Sheet

Total Cash(mrq)

22.07M

Total Cash Per Share(mrq)

16.28

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

65.36%

Quick Ratio(mrq)

65.34%

Book Value Per Share(mrq)

9.67

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.82

Free Cash Flow(ytd)

-3.72M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement